Table 5. Associations between disease characteristics and myocardial work indices.
| Variables | Tumor type | Treatment regimen | Cardiovascular risk factors | Cardiovascular drugs | irAEs | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F | P value | F | P value | F | P value | F | P value | F | P value | |||||
| PSD | 0.372 | 0.545 | 0.437 | 0.648 | 0.615 | 0.545 | 0.004 | 0.950 | 2.388 | 0.080 | ||||
| GLS | 0.868 | 0.356 | 1.212 | 0.306 | 0.353 | 0.705 | 0.124 | 0.726 | 3.314 | 0.034 | ||||
| GWI | 3.937 | 0.053 | 0.767 | 0.470 | 1.060 | 0.354 | 0.884 | 0.352 | 1.746 | 0.170 | ||||
| GCW | 2.547 | 0.117 | 0.407 | 0.668 | 1.234 | 0.300 | 3.936 | 0.053 | 1.227 | 0.310 | ||||
| GWW | 0.061 | 0.805 | 0.406 | 0.668 | 0.409 | 0.667 | 0.209 | 0.650 | 18.614 | <0.001 | ||||
| GWE | 0.252 | 0.618 | 0.461 | 0.633 | 0.235 | 0.792 | 0.024 | 0.878 | 20.224 | <0.001 | ||||
PSD, peak strain dispersion; GLS, global longitudinal strain; GWI, global work index; GCW, global constructive work; GWW, global wasted work; GWE, global work efficiency; irAE, immune-related adverse event.